drugset / Trial / NCT01844310
Raltegravir-based Antiretroviral Therapy for Resistant HIV-1 Infection
RandomizedParallel-groupOpen-labelTreatment
Summary
This study is to evaluate the safety and efficacy of RAL-based regimen in treatment-experienced patients with resistant HIV infection
Timeline
- Start
- 2013-05
- Primary completion
- 2015-12
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Lamivudine | Other / unclassified | — | — |
| Comparator | Raltegravir | Other / unclassified | — | — |
| Comparator | KELETRA | Unknown | — | — |
| Comparator | TDF | Unknown | — | — |